Results 91 to 100 of about 463,247 (329)

Increased Prevalence of Barrett's Esophagus in Taiwan: A Prospective Multicenter Study

Journal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Background and Aim With rising rates of esophageal adenocarcinoma (EAC) in Western countries, Barrett's esophagus (BE) has become a growing concern. The increasing prevalence of chronic gastroesophageal reflux disease (GERD) in Taiwan suggests a potential rise in BE cases as well.
Fu‐Jen Lee, Ming‐Chang Tsai, Chien‐Lin Chen, Ming‐Wun Wong, Hsu‐Heng Yen, Jeng‐Yih Wu, Chen‐Shuan Chung, Ping‐Huei Tseng, Ying‐Nan Tsai, Ming‐Tsung Hsieh, Chi‐Yang Chang   +10 more
wiley   +1 more source

Multicentric Adenocarcinomas in a Long-Segment of Barrett's Esophagus

Clinical Medicine Insights: Oncology, 2008
This report describes a complicated course of a 58-year-old patient with multicentric Barrett's carcinoma within a long-segment of Barrett metaplasia.
Stefan Hartl, Joerg-Ruediger Siewert FACS, Joerg Theisen   +2 more
doaj   +1 more source

Cryotherapy versus radiofrequency ablation in the treatment of dysplastic Barrett’s esophagus with or without early esophageal neoplasia: a systematic review and meta-analysis [PDF]

Clinical Endoscopy
Background/Aims Radiofrequency ablation (RFA) is the first-line therapy for dysplastic Barrett’s esophagus (BE). Therefore, cryotherapy has emerged as an alternative treatment option.
Igor Logetto Caetité Gomes, Diogo Turiani Hourneaux de Moura, Igor Braga Ribeiro, Sérgio Barbosa Marques, Alexandre de Sousa Carlos, Beanie Conceição Medeiros Nunes, Bruno Salomão Hirsch, Guilherme Henrique Peixoto de Oliveira, Roberto Paolo Trasolini, Wanderley Marques Bernardo, Eduardo Guimarães Hourneaux de Moura   +10 more
doaj   +1 more source

Quality Upper Gastrointestinal Endoscopy in Australia and Aotearoa New Zealand: A Joint Position Statement

Journal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Quality standards for upper gastrointestinal (UGI) endoscopy are required to identify key quality indicators that are relevant to Australasian endoscopic practice and local patient populations. Such standards will promote equitable access to high‐quality UGI endoscopy for appropriate indications across Australia and Aotearoa New Zealand.
Linda S. Yang, Abir Halder, Bronte A. Holt, Benedict Devereaux, Matthew Remedios, Neil Merrett, Marianne Lill, Zoe Raos, Malcolm Arnold, Nicholas G. Burgess, Sneha John, Krish Ragunath   +11 more
wiley   +1 more source

An investigation of the progression from Barrett's esophagus to adenocarcinoma [PDF]

, 2016
Barrett's esophagus is a metaplasia of the epithelium of the lower esophagus from a normal squamous appearance to a columnar appearance more typically found in the stomach. It is normally caused by prolonged gastric reflux. While Barrett's esophagus is
Palmese, Scott Joseph
core   +1 more source

Histopathology in Barrett Esophagus and Barrett Esophagus-Related Dysplasia

Clinical Endoscopy, 2014
Pathologic specimens, both biopsies and endoscopic mucosal resections, for Barrett esophagus and Barrett-associated dysplasia and malignancy are common for pathologists in North America, and the incidence in South Asian countries seems to be increasing.
Andrea Grin, Catherine J. Streutker
openaire   +3 more sources

Esófago de Barrett y su manejo Barrett's esophagus and its management

Revista Colombiana de Cirugía, 2005
Se hace un recuento histórico del esófago de Barrett desde su descripción por Norman Barrett en 1950. Se discute la evolución del concepto. Se definen el esófago de Barrett corto y largo, su prevalencia y diagnóstico.
Mario Melguizo Bermúdez
doaj  

O critério de positividade para a análise imunoistoquímica da p53 na confirmação da displasia do esôfago de Barrett faz diferença? Does positive criterium for p53 immunohistochemical analysis in the confirmation of Barrett's dysplasia make difference?

Arquivos de Gastroenterologia, 2005
RACIONAL: O esôfago de Barrett é uma complicação da doença do refluxo gastroesofágico com importante potencial de malignização. Relata-se que a expressão do marcador tumoral p53 se acentua com a progressão displasia-adenocarcinoma.
César Vivian Lopes, Júlio C. Pereira-Lima, Antônio Atalíbio Hartmann, Eunice Tonelotto, Karina Salgado   +4 more
doaj   +1 more source

Buried Barrett’s Esophagus with High-Grade Dysplasia after Radiofrequency Ablation [PDF]

Clinical Endoscopy, 2019
Radiofrequency ablation therapy is an effective endoscopic option for the eradication of Barrett’s esophagus that appears to reduce the risk of esophageal cancer.
Joana Castela, Miguel Serrano, Susana Mão de Ferro, Daniela Vinha Pereira, Paula Chaves, António Dias Pereira   +5 more
doaj   +1 more source

Generalizable Cone Beam CT Esophagus Segmentation Using Physics-Based Data Augmentation [PDF]

arXiv, 2020
Automated segmentation of esophagus is critical in image guided/adaptive radiotherapy of lung cancer to minimize radiation-induced toxicities such as acute esophagitis. We developed a semantic physics-based data augmentation method for segmenting esophagus in both planning CT (pCT) and cone-beam CT (CBCT) using 3D convolutional neural networks.
arxiv